menu
    • menu

    Company profile for Clene Nanomedicine

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-mole...
    Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clene NanomedicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3165 East Millrock Drive, Suite 325 Salt Lake City, Utah 84121
    Telephone
    Telephone
    1-801-676-9695
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clene-nanomedicine
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clene To Present At The Emerging Growth Conference
    Clene To Present At The Emerging Growth Conference

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202339/0/en/Clene-to-Present-at-the-Emerging-Growth-Conference.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Clene Announces ALS Data Backing CNM-Au8 Accelerated Approval
    Clene Announces ALS Data Backing CNM-Au8 Accelerated Approval

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198843/0/en/Clene-Announces-Statistically-Significant-ALS-Biomarker-Results-Supporting-Accelerated-Approval-Pathway-for-CNM-Au8.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Clene To Provide CNM-Au8® ALS Program Update
    Clene To Provide CNM-Au8® ALS Program Update

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3198482/0/en/Clene-to-Provide-CNM-Au8-ALS-Program-Update.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Clene To Attend Benchmark Investor Conference
    Clene To Attend Benchmark Investor Conference

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191838/0/en/Clene-to-Participate-at-the-Benchmark-14th-Annual-Discovery-One-on-One-Investor-Conference.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Clene Unveils Q3 2025 Financials And Operating Updates
    Clene Unveils Q3 2025 Financials And Operating Updates

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187278/0/en/Clene-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Operating-Highlights.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Clene To Present At The Emerging Growth Conference
    Clene To Present At The Emerging Growth Conference

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169378/0/en/Clene-to-Present-at-the-Emerging-Growth-Conference.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search